Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature development.

We aimed to develop an anti-angiogenic model for breast cancer by combining (1) siRNA-based therapy delivered by self-complementary adeno-associated virus serotype 2 (scAAV2) vectors to target tumor vasculature, and (2) noninvasive monitoring to tumor response to anti-angiogenesis by photoacoustic (PA) imaging. scAAV2 vector containing 7 surface exposed tyrosine to phenylanine capsid mutations was able to transduce microvascular endothelial cells with high efficiency. siRNAs against UPR (unfolded protein response)-IRE1α, XBP-1, ATF6 significantly inhibited breast cancer-induced angiogenesis in vitro by inhibiting endothelial cell survival. PA imaging showed that knockdown of UPR proteins greatly reduced tumor angiogenesis in vivo in breast cancer models.

[1]  L. Govindasamy,et al.  A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  O. Devuyst,et al.  Recombinant adenovirus administration in rat peritoneum: endothelial expression and safety concerns. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  M. Odenthal,et al.  Vascular bed-targeted in vivo gene delivery using tropism-modified adeno-associated viruses. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Junjie Yao,et al.  VEGF is essential for hypoxia-inducible factor-mediated neovascularization but dispensable for endothelial sprouting , 2011, Proceedings of the National Academy of Sciences.

[5]  C. Halbert,et al.  Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo. , 2000, Physiological genomics.

[6]  M. Hallek,et al.  Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  M. Huang,et al.  Ultrasound-guided optical tomographic imaging of malignant and benign breast lesions: initial clinical results of 19 cases. , 2003, Neoplasia.

[8]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[9]  Lihong V. Wang,et al.  Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging , 2006, Nature Biotechnology.

[10]  W. Jiang,et al.  αB-Crystallin, an Effector of Unfolded Protein Response, Confers Anti-VEGF Resistance to Breast Cancer via Maintenance of Intracrine VEGF in Endothelial Cells , 2011, Molecular Cancer Research.

[11]  W. Jiang,et al.  Pigment Epithelium-derived Factor Inhibits Angiogenesis via Regulated Intracellular Proteolysis of Vascular Endothelial Growth Factor Receptor 1* , 2006, Journal of Biological Chemistry.

[12]  B. Law,et al.  Mammary tumors initiated by constitutive Cdk2 activation contain an invasive basal-like component. , 2008, Neoplasia.

[13]  M. Boulton,et al.  The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. , 2008, Investigative ophthalmology & visual science.

[14]  T. Giles,et al.  Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Patrick J. Paddison,et al.  Stable suppression of gene expression by RNAi in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Koong,et al.  Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth. , 2010, Cancer research.

[17]  R. Bernards,et al.  Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.

[18]  W. Hauswirth,et al.  Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial. , 2008, Human gene therapy.

[19]  M. Leach,et al.  Measuring changes in human tumour vasculature in response to therapy using functional imaging techniques , 2001, British Journal of Cancer.

[20]  S. Nicklin,et al.  Adeno-associated virus (AAV)-7 and -8 poorly transduce vascular endothelial cells and are sensitive to proteasomal degradation , 2005, Gene Therapy.

[21]  Kenneth I. Berns,et al.  Gene Therapy Using Adeno-Associated Virus Vectors , 2008, Clinical Microbiology Reviews.

[22]  John J. Rossi,et al.  Strategies for silencing human disease using RNA interference , 2007, Nature Reviews Genetics.

[23]  R. Kaufman,et al.  ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. , 2007, Developmental cell.

[24]  Lihong V. Wang,et al.  Photoacoustic endoscopy. , 2009, Optics letters.

[25]  N. Muzyczka,et al.  Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. , 2008, Virology.

[26]  T. Kafri,et al.  Gene delivery by lentivirus vectors , 2007, Molecular biotechnology.

[27]  Hua-bei Jiang,et al.  Design and evaluation of a hybrid photoacoustic tomography and diffuse optical tomography system for breast cancer detection. , 2012, Medical physics.

[28]  Nizar M. Mhaidat,et al.  Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. , 2007, Cancer research.

[29]  H M Jensen,et al.  Angiogenesis induced by "normal" human breast tissue: a probable marker for precancer. , 1982, Science.

[30]  W. Hauswirth,et al.  Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines , 2011, Molecular vision.

[31]  R. Donis,et al.  Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine , 2012, PloS one.

[32]  J. Aguirre-Ghiso,et al.  ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo , 2008, Proceedings of the National Academy of Sciences.

[33]  Anastasia Khvorova,et al.  Induction of the interferon response by siRNA is cell type- and duplex length-dependent. , 2006, RNA.

[34]  W. Hauswirth,et al.  Light-driven cone arrestin translocation in cones of postnatal guanylate cyclase-1 knockout mouse retina treated with AAV-GC1. , 2006, Investigative ophthalmology & visual science.

[35]  W. Hauswirth,et al.  Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors. , 2002, Methods.

[36]  W. Hauswirth,et al.  γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines. , 2012, Investigative ophthalmology & visual science.

[37]  Aiqing He,et al.  The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[38]  Mert R. Sabuncu,et al.  Entropy-based Image Registration , 2006 .

[39]  Pratima Chowdary,et al.  Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. , 2011, The New England journal of medicine.

[40]  R. Iggo,et al.  Induction of an interferon response by RNAi vectors in mammalian cells , 2003, Nature Genetics.

[41]  G. Jayandharan,et al.  High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy. , 2010, Human gene therapy.

[42]  Dai Fukumura,et al.  Imaging angiogenesis and the microenvironment   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[43]  V. Nair.  Retrovirus-induced oncogenesis and safety of retroviral vectors. , 2008, Current opinion in molecular therapeutics.

[44]  K. Mori,et al.  XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor , 2001, Cell.

[45]  A. Koong,et al.  The Unfolded Protein Response: A Novel Component of the Hypoxic Stress Response in Tumors , 2005, Molecular Cancer Research.

[46]  Jonathan S Weissman,et al.  Decay of Endoplasmic Reticulum-Localized mRNAs During the Unfolded Protein Response , 2006, Science.

[47]  W. Jiang,et al.  Vascular endothelial growth factor-induced endothelial cell proliferation is regulated by interaction between VEGFR-2, SH-PTP1 and eNOS. , 2006, Microvascular research.

[48]  Stevan R. Hubbard,et al.  IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA , 2002, Nature.

[49]  R. Kaufman,et al.  Differential contributions of ATF6 and XBP1 to the activation of endoplasmic reticulum stress-responsive cis-acting elements ERSE, UPRE and ERSE-II. , 2004, Journal of biochemistry.